Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

Covid-19 : 82 forms

Sorting of results :

SAPRIS-SERO - HEALTH, PERCEPTION, PRACTICES, AND SOCIAL RELATIONS AND INEQUALITIES AMONG THE GENERAL POPULATION DURING THE COVID-19 CRISIS – SEROLOGY (SAPRIS-SERO).

Head : CARRAT Fabrice, IPLESP - U1136
ZINS Marie, UMS 11
SEVERI Gianluca, CESP UMR U1018
CHARLES Marie-Aline, UMS Ined Inserm Elfe
ANCEL Pierre-Yves, CRESS UR1153
TOUVIER Mathilde, CRESS-EREN UMR U1153 Inserm

Version 1
Voir
View
Overview

37

Last update : 05/05/2021

SAPRIS-SERO - HEALTH, PERCEPTION, PRACTICES, AND SOCIAL RELATIONS AND INEQUALITIES AMONG THE GENERAL POPULATION DURING THE COVID-19 CRISIS – SEROLOGY (SAPRIS-SERO).

Head : CARRAT Fabrice, IPLESP - U1136
ZINS Marie, UMS 11
SEVERI Gianluca, CESP UMR U1018
CHARLES Marie-Aline, UMS Ined Inserm Elfe
ANCEL Pierre-Yves, CRESS UR1153
TOUVIER Mathilde, CRESS-EREN UMR U1153 Inserm

Main objective

Based on the collection of capillary blood samples taken by the subjects, SAPRIS-SERO will help to:
• Estimate the cumulative incidence of infection in the general population (objective 1a),
• Characterise the “immune” portion of the population and the durability of immunity (objective 1b).

Inclusion criteria

Be a participant in one of the cohorts involved in the SAPRIS project, or a person sharing the same accommodation

Last update : 05/05/2021

Voir
View

- Forgoing care during the lockdown period due to the COVID-19 epidemic

Head : Douillet Delphine, MITOVASC

Version 1
Voir
View
Overview

38

Last update : 05/05/2021

- Forgoing care during the lockdown period due to the COVID-19 epidemic

Head : Douillet Delphine, MITOVASC

Main objective

Compare the rate of patients forgoing care during the lockdown period in France, in emergency facilities at Angers and Le Mans hospitals, with that observed during a previous study in 2017.

Inclusion criteria

All adult patients having attended the A&E department at Angers University Hospital and Le Mans Hospital, able and agreeing to complete the questionnaires directly or with the assistance of a translator.

Last update : 05/05/2021

Voir
View

COVID-OISE - Longitudinal follow-up of a population-based cohort in a French town with intense SARS-CoV-2 circulation in early 2020.

Head : FONTANET Arnaud, Emerging Diseases Epidemiology Unit

Version 1
Voir
View
Overview

39

Last update : 05/05/2021

COVID-OISE - Longitudinal follow-up of a population-based cohort in a French town with intense SARS-CoV-2 circulation in early 2020.

Head : FONTANET Arnaud, Emerging Diseases Epidemiology Unit

Main objective

Study the changes over time of the specific humoral response generated by SARS-CoV-2 virus infection in different biological specimens from subjects in different age groups.

Inclusion criteria

1. Person living, working or studying in Crépy-en-Valois or in the surrounding towns
OR in the same household as one of the above persons
OR professional, resident or patient in retirement homes or the Saint-Lazare Hospital long-stay healthcare facility, in Crépy-en-Valois
2. Adult or minor subject from 5 years of age
3. Individual covered by a social security scheme
4. Individual having given their consent to take part in the study after reviewing the information provided by a qualified person representing the principal investigator

Last update : 05/05/2021

Voir
View

NOSO-COR Project - Multicenter study on nosocomial transmission of SARS-CoV2 virus

Head : Philippe VANHEMS , Laboratoire des Pathogènes Emergents, Fondation Mérieux, / Service Hygiène, Epidémiologie et Prévention

Version 1
Voir
View
Overview

40

Last update : 09/22/2021

NOSO-COR Project - Multicenter study on nosocomial transmission of SARS-CoV2 virus

Head : Philippe VANHEMS , Laboratoire des Pathogènes Emergents, Fondation Mérieux, / Service Hygiène, Epidémiologie et Prévention

Main objective

Describe and document suspected or confirmed cases of SARS-CoV2 nosocomial infections, their clinical spectrum and the determinants (risk factors / protection) at the participating hospitals.

Inclusion criteria

Any voluntary adult or child or any healthcare workers from the study participant hospital who presents an infectious syndrome including the following definitions and oral/written informed consent obtained from parent/guardian for children < 18-years-old. (upon ethical requirements at each participant site).

Definitions
Suspect Case:
- Fever above 37.8 ° C if no antipyretics are taken; And or
- Cough or pharyngeal pain or other symptom suggestive of respiratory infection.
AND at least 1 of the following characteristics:
- return from a trip to China, or to a country in which the increase in the incidence of infections in SARS-CoV2 has been proven;
- close contact (sharing the same place of family, professional life, same plane, etc.) with a person defined as a suspected or confirmed case;
- Occurring in a hospital having received at least one suspected or confirmed case of SARS-CoV2 infection.


Confirmed Case
- The same clinical definitions, in addition to a positive RT-PCR-type virological diagnostic result specific to SARS-CoV2.

Last update : 09/22/2021

Voir
View

COVIDOR - Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public

Head : SERREAU Raphaël, PARADICT-O

Version 1
Voir
View
Overview

41

Last update : 03/11/2021

COVIDOR - Epidemiological Study of the Covid-19 Presto Test Among Agents of the Local Authorities of CCTVL, Region Centre Val de Loire and Orleans Métropole. Correlation of IgM Level According to Contact With the Public

Head : SERREAU Raphaël, PARADICT-O

Main objective

To collect health data about conditions workers and covid-19 serology status in Orleans Metropole, Loiret District and the Centre Val de Loire Region

Inclusion criteria

Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Sampling Method: Non-Probability Sample

Last update : 03/11/2021

Voir
View

EPIC - Descriptive, prognostic study of SARS-CoV-2 coronavirus infection in Martinique, conducted in a hospital cohort of patients with probable or confirmed COVID-19 infection

Head : CABIEChabartier AndréCyrille, French West Indies - Guiana CIC - Inserm 1424 - Infectious, genetic and emerging diseases in tropical regions
Chabartier Cyrille

Version 1
Voir
View
Overview

42

Last update : 05/07/2021

EPIC - Descriptive, prognostic study of SARS-CoV-2 coronavirus infection in Martinique, conducted in a hospital cohort of patients with probable or confirmed COVID-19 infection

Head : CABIEChabartier AndréCyrille, French West Indies - Guiana CIC - Inserm 1424 - Infectious, genetic and emerging diseases in tropical regions
Chabartier Cyrille

Main objective

Identify the demographic, clinical, biological, virological and immunological factors associated with, or predictive of the onset of a severe form of COVID-19 in a cohort of children and adults managed in a hospital setting at Martinique University Hospital.

Inclusion criteria

Inclusion criterion: Patient hospitalised in a COVID-specific treatment unit, including intensive care, for possible or confirmed SARS-CoV-2 infection (PCR+ and/or CT scan consistent with infection) at Martinique University Hospital.
Exclusion criterion: Refusal to take part, by the patient or their legal representative
Exclusion criteria: patient with confirmed diagnosis of infection with a pathogen other than SARS-CoV-2, and no likelihood of co-infection with SARS-CoV-2

Last update : 05/07/2021

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here